President Trump announced landmark drug pricing agreements with nine pharmaceutical companies and the launch of TrumpRx.gov, ...

The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.

The talks follow the administration’s push to lower U.S. drug prices using trade and regulatory leverage. ・Pfizer and ...

Pfizer Inc. (NYSE:PFE) today provided its full-year 2026 guidance(2) while revising its November 4, 2025 full-year 2025 Revenue guidance(2) and ...

The U.S. stock market drifted through a mixed day of trading Tuesday after reports on the economy did little to clear uncertainty about where interest rates may ...

Major stock indexes pulled back sharply Tuesday after the November U.S. nonfarm payrolls report revealed greater employment ...

Amid profit forecast reductions, Pfizer is implementing a $7.7bn cost-cutting strategy, while investing into its ...

Pfizer Inc. (NYSE:PFE) today provided its full-year 2026 guidance(2) while revising its November 4, 2025 full-year 2025 ...

Pfizer last month closed its up to $10bn (€8.5bn) acquisition of Metsera after winning shareholder approval, gaining a ...

Pfizer on Tuesday forecast 2026 profit below Wall Street estimates as it expects a steep drop in sales of its COVID products ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Last week, the Federal Reserve delivered a quarter-point rate cut at the close of its October meeting, lowering the benchmark rate to a range of 3.75% to 4%, with the goal of helping to ease borrowing ...